Advertisement

Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: A Reference, Not a Rule Book

Published:January 12, 2018DOI:https://doi.org/10.1016/j.amepre.2017.11.013
      Cost-effectiveness analysis (CEA), as noted by the Second Panel on Cost Effectiveness in Health and Medicine (herein, the Second Panel), “provides a framework for comparing the relative value of different interventions, along with information that can help decision makers sort through alternatives and decide which ones best serve their programmatic and financial needs.”
      • Sanders G.D.
      • Neumann P.J.
      • Basu A.
      • et al.
      Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
      The CEA, as well as other methods of economic evaluation, such as budgetary impact analysis and cost−benefit analysis, can inform health policy decisions. In 1996, the first Panel on Cost Effectiveness in Health and Medicine (herein, the First Panel) issued recommendations intended to improve the quality and comparability of CEA studies.
      • Gold M.R.
      • Siegel J.E.
      • Russell L.B.
      • Weinstein M.C.
      Cost-Effectiveness in Health and Medicine.
      The Second Panel has provided updated recommendations on the conduct, documentation, and reporting of CEAs with the same general intent.
      • Neumann P.J.
      • Sanders G.D.
      • Russell L.B.
      • Siegel J.E.
      • Ganiats T.G.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sanders G.D.
        • Neumann P.J.
        • Basu A.
        • et al.
        Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
        JAMA. 2016; 316: 1093-1103https://doi.org/10.1001/jama.2016.12195
        • Gold M.R.
        • Siegel J.E.
        • Russell L.B.
        • Weinstein M.C.
        Cost-Effectiveness in Health and Medicine.
        Oxford University Press, New York, NY1996
        • Neumann P.J.
        • Sanders G.D.
        • Russell L.B.
        • Siegel J.E.
        • Ganiats T.G.
        Cost-Effectiveness in Health and Medicine. 2nd ed. Oxford University Press, New York, NY2016https://doi.org/10.1093/acprof:oso/9780190492939.001.0001
        • Gift T.L.
        • Haddix A.C.
        • Corso P.S.
        Cost-effectiveness analysis.
        in: Haddix A.C. Teutsch S.M. Corso P.S. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. Oxford University Press, New York, NY2003
        • Nurmagambetov T.A.
        • Barnett S.B.
        • Jacob V.
        • et al.
        Economic value of home-based, multi-trigger, multicomponent interventions with an environmental focus for reducing asthma morbidity: a Community Guide systematic review.
        Am J Prev Med. 2011; 41: S33-S47https://doi.org/10.1016/j.amepre.2011.05.011
        • Grosse S.D.
        • Berry R.J.
        • Tilford J.M.
        • Kucik J.E.
        • Waitzman N.J.
        Retrospective assessment of the cost savings of prevention: folic acid fortification and spina bifida in the U.S..
        Am J Prev Med. 2016; 50: S74-S80https://doi.org/10.1016/j.amepre.2015.10.012
        • Zhou F.
        • Shefer A.
        • Wenger J.
        • et al.
        Economic evaluation of the routine childhood immunization program in the United States, 2009.
        Pediatrics. 2014; 133: 577-585https://doi.org/10.1542/peds.2013-0698
        • Drost R.M.
        • van der Putten I.M.
        • Ruwaard D.
        • Evers S.M.
        • Paulus A.T.
        Conceptualizations of the societal perspective within economic evaluations: a systematic review.
        Int J Technol Assess Health Care. 2017; 33: 251-260https://doi.org/10.1017/S0266462317000526
        • Cloutier M.M.
        • Grosse S.D.
        • Wakefield D.B.
        • Nurmagambetov T.A.
        • Brown C.M.
        The economic impact of an urban asthma management program.
        Am J Manag Care. 2009; 15: 345-351